Golden State Medical Supply Inc. has recalled approximately 234,296 bottles of Losartan Potassium (25 mg and 100 mg), a medication used to treat high blood pressure. Testing confirmed that the tablets contain an impurity called N-Methylnitrosobutyric acid (NMBA) at levels higher than what the FDA considers acceptable for daily intake. These products were distributed to various healthcare accounts in several states and government facilities.
NMBA is a suspected human carcinogen, meaning long-term exposure to levels above the interim acceptable daily intake could potentially increase the risk of cancer. While no immediate health issues have been reported, the levels found in these specific batches exceeded safety guidelines set by the manufacturer.
Contact healthcare provider and return product for refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.